Drug Shortage Report for JAMP-OLOPATADINE
Report ID | 202886 |
Drug Identification Number | 02458411 |
Brand name | JAMP-OLOPATADINE |
Common or Proper name | Olopatadine Hydrochloride Ophthalmic Solution |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | OLOPATADINE |
Strength(s) | 0.1% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5 mL |
ATC code | S01GX |
ATC description | DECONGESTANTS AND ANTIALLERGICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-08-24 |
Estimated end date | 2024-12-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-30 |
Company comments | Increase in demand / under allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2024-03-30 | French | Compare |
v8 | 2024-03-30 | English | Compare |
v7 | 2023-11-28 | French | Compare |
v6 | 2023-11-28 | English | Compare |
v5 | 2023-10-02 | French | Compare |
v4 | 2023-10-02 | English | Compare |
v3 | 2023-08-25 | English | Compare |
v2 | 2023-08-24 | French | Compare |
v1 | 2023-08-24 | English | Compare |
Showing 1 to 9 of 9